LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
8.94
-0.13 (-1.43%)
Mar 26, 2026, 4:00 PM EDT - Market closed
LENZ Therapeutics Employees
LENZ Therapeutics had 152 employees as of December 31, 2025. The number of employees increased by 110 or 261.90% compared to the previous year.
Employees
152
Change (1Y)
110
Growth (1Y)
261.90%
Revenue / Employee
$125,579
Profits / Employee
-$540,309
Market Cap
280.31M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 152 | 110 | 261.90% |
| Dec 31, 2024 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AC Immune | 172 |
| Foghorn Therapeutics | 106 |
| Enlivex | 71 |
| Orchestra BioMed Holdings | 70 |
| Protara Therapeutics | 46 |
| ALX Oncology Holdings | 43 |
| Anavex Life Sciences | 34 |
| NovaBridge Biosciences | 32 |
LENZ News
- 2 days ago - LENZ Therapeutics, Inc. (LENZ) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 9 days ago - LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026 - GlobeNewsWire
- 16 days ago - LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia - GlobeNewsWire
- 4 weeks ago - LENZ Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Calamos Timpani Small Cap Growth Fund Q4 2025 Contributors And Detractors - Seeking Alpha
- 7 weeks ago - New FDA-Approved Eye Drop Sparks Fresh Competition For LENZ Therapeutics' Drug - Benzinga
- 2 months ago - LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign - GlobeNewsWire